Goodbye 2016: The Year in Review
Happy New Year! It is that time of the year again when we take the time to look back and review the previous year. Probably the most striking thing I see is the sheer volume [...]
Happy New Year! It is that time of the year again when we take the time to look back and review the previous year. Probably the most striking thing I see is the sheer volume [...]
When a woman comes in for a consultation regarding the use of medications during pregnancy, we spend most of our time reviewing the potential risks of exposure to medications during pregnancy. However, we must also [...]
Next week we will be reviewing two important articles which look at the effects of maternal depression on the developing brain of the child: one from Posner and colleagues and another from Lebel and colleagues. [...]
The research of Lynne Murray and Peter Cooper in the 1990s was pivotal in terms of demonstrating the negative effects of postpartum depression on the cognitive development of young children and played an important role [...]
There is significant literature indicating that a mother’s depression may adversely affect her young child. Studies have demonstrated that the children of depressed mothers are more likely than the children of non-depressed mothers to exhibit [...]
Katherine Stone, the founder of Postpartum Progress, has long been an advocate for women with perinatal mood and anxiety disorders. In addition to her website which provides information and support, she has helped to create [...]
There is some legislation being considered in the House and Senate that all of you -- health care providers, advocates, women and their families and friends -- should know about: H.R. 3235: Bringing Postpartum Depression [...]
Some, but not all, studies have shown an association between in utero exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants and adverse pregnancy outcomes, including preterm delivery, low birth weight, and lower Apgar scores. [...]
SAGE-547 (SAGE Therapeutics) is a new drug, an allosteric modulator of GABAA receptors, which is currently under investigation for the treatment of refractory seizure disorders. It turns out that SAGE-547 may also be useful for [...]
Multiple studies have shown that postpartum depression can interfere with bonding between the mother and her infant. While new fathers may also develop depression, little is known about how depression in the father affects bonding. [...]